Potent insulin sensitizing agent. Peroxisome proliferator-activated receptor γ (PPAR-γ) agonist. Hepatotoxic. Antidiabetic.
Product Details
| Formula: | C18H19N3O3S |
| |
| MW: | 357.4 |
| |
| CAS: | 122320-73-4 |
| |
| MI: | 14: 8265 |
| |
| Purity: | ≥97% (HPLC) |
| |
| Appearance: | White to off-white solid. |
| |
| Solubility: | Soluble in DMSO (>25mg/ml), 100% ethanol or methanol. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | +4°C |
| |
| Use/Stability: | Stable for 2 years after receipt when stored at +4°C. Stock solutions are stable for up to 3 months when stored at -20°C. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Differential effects of dolutegravir, bictegravir and raltegravir in adipokines and inflammation markers on human adipocytes: P. Domingo, et al.; Life Scienes
308, 120948 (2022),
Abstract;
Role of respiratory uncoupling in drug-induced mitochondrial permeability transition: T. Sato, et al.; Toxicol. Appl. Pharmacol.
427, 115659 (2021),
Abstract;
A PPAR-gamma agonist protects from radiation-induced intestinal toxicity: M. Mangoni, et al.; United European Gastroenterol. J.
5, 218 (2017),
Application(s): Cell culture,
Abstract;
Full Text
A combination of (+)-catechin and (-)-epicatechin underlies the in vitro adipogenic action of Labrador tea (Rhododendron groenlandicum), an antidiabetic medicinal plant of the Eastern James Bay Cree pharmacopeia: H.M. Eid, et al. ; J. Ethnopharmacol.
178, 251 (2016),
Application(s): Cell culture,
Abstract;
ECM microenvironment unlocks brown adipogenic potential of adult human bone marrow-derived MSCs: M.H. Lee, et al.; Sci. Rep.
6, 21173 (2016),
Application(s): Cell culture,
Abstract;
Full Text
Effect of intranasal rosiglitazone on airway inflammation and remodeling in a murine model of chronic asthma: H.Y. Lee, et al.; Korean J. Intern. Med.
31, 89 (2016),
Application(s): Cell culture,
Abstract;
Full Text
Effects of alpha-lipoic acid on chemerin secretion in 3 T3-L1 and human adipocytes: P.L. Prieto-Hontoria, et al. ; Biochim. Biophys. Acta
1861, 260 (2016),
Application(s): Cell culture,
Abstract;
A Novel Peroxisome Proliferator-activated Receptor (PPAR)α Agonist and PPARγ Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice: Y. Shiomi, et al.; J. Biol. Chem.
290, 14567 (2015),
Application(s): Cell Culture,
Abstract;
Full Text
Expression of human and mouse adenine nucleotide translocase (ANT) isoform genes in adipogenesis: A. Gavaldà-Navarro, et al.; Int. J. Biochem. Cell. Biol.
64, 34 (2015),
Application(s): Cell Culture,
Abstract;
Rosiglitzone Suppresses Angiotensin II-Induced Production of KLF5 and Cell Proliferation in Rat Vascular Smooth Muscle Cells: D. Gao, et al.; PLoS One
10, e0123724 (2015),
Application(s): Cell Culture,
Abstract;
Full Text
Modulation of RAGE and the Downstream Targets of RAGE Signaling Cascades by Taurine in Lycium Barbarum (Goji Berry): Protection of Human Retinal Pigment Epithelial Barrier Function and its Potential Benefit in Diabetic Retinopathy: M.K. Song, et al.; J. Diabetes Metab.
2, 162 (2011),
Application(s): Cell Culture,
Full Text
A review of rosiglitazone in type 2 diabetes mellitus: A.L. Werner & M.T. Travaglini; Pharmacotherapy
21, 1082 (2001), (Review),
Abstract;
Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions: M. McMorran & D. Vu; CMAJ
165, 82 (2001),
Abstract;
Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review: J.M. Malinowski & S. Bolesta; Clin. Ther.
22, 1151 (2000), (Review),
Abstract;
Rosiglitazone: an agent from the thiazolidinedione class for the treatment of type 2 diabetes: A. Cheng-Lai & A. Levine; Heart Dis.
2, 326 (2000), (Review),
Abstract;
Differential effects of insulin-sensitizers troglitazone and rosiglitazone on ion currents in rat vascular myocytes: G.A. Knock, et al.; Eur. J. Pharmacol.
368, 103 (1999),
Abstract;
Rosiglitazone: J.A. Balfour & G.L. Plosker; Drugs
57, 921 (1999), (Review) ,
Abstract;
Differential activity of rosiglitazone enantiomers at PPAR gamma: D.J. Parks, et al.; Bioorg. Med. Chem. Lett.
81, 3657 (1998),
Abstract;
